Cargando…
Use of azithromycin in the treatment of acute exacerbations of COPD
Chronic bronchitis is a relatively common entity among patients with underlying chronic obstructive lung disease. Typical treatment includes pulmonary hygiene, bronchodilators, and antimicrobial therapy. In recent years, the duration of antimicrobial therapy in acute exacerbations of COPD has become...
Autor principal: | Milstone, Aaron P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650599/ https://www.ncbi.nlm.nih.gov/pubmed/19281070 |
Ejemplares similares
-
1297. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2021) -
Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD
por: Baalbaki, Nour, et al.
Publicado: (2022) -
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
por: Ra, Seung Won, et al.
Publicado: (2017) -
Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013) -
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
por: Pomares, Xavier, et al.
Publicado: (2011)